Articles

Miglitol decreased hunger and increased feelings of satiety after a meal in obese, diabetic patients

Are the current definitions of impaired glucose tolerance (IGT) and impaired fasting glycemia (IFG) appropriate? Are IFG and IGT risk factors, risk markers or diseases? These are just a couple of the questions addressed.

Treatment with the ACE inhibitor ramipril may help prevent the development of diabetes as well as lower the risk of heart attack, stroke, and cardiovascular mortality in patients at high risk for cardiovascular events.

A group of researchers led by Dr Johannes Plank from the Karl-Franzens University of Graz in Austria, compared the pharmacokinetic and pharmacodynamic profiles of insulin aspart and insulin lispro and their effects on postprandial blood glucose excursions in patients with type 1 diabetes.

The use of medications for diabetes is a marker for underlying disease severity.

Visceral fat removal can halt a decrease in insulin action and delay the onset of diabetes. researchers report in the October issue of Diabetes.

Doc’s would be able to bill 15% more for services if they can show better outcomes then the norm.

Stroke patients see 38% reduction in risk of nonfatal MIs, 26% drop in CHF risk.

Visceral adiposity is associated with both peripheral and hepatic insulin resistance, independent of gender, in the type 2 diabetic patients

The use of thiazolidinediones as a strategy for blood glucose lowering in type 2 diabetics may be associated with a reduced risk of myocardial infarction (MI).